Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
Title | FOA | Organization | Release Date Sort descending | Expire Date | Purpose |
---|---|---|---|---|---|
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional) | PAR-24-110 | NIMHD | The objective of this funding opportunity is to support non-pharmacological interventions to promote sleep health, reduce sleep health disparities, and examine sleep as a modifiable factor to reduce… More | ||
Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed) | RFA-CA-24-023 | NCI | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also… More | ||
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) | PA-24-190 | NIH | The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has… More | ||
Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional) | RFA-DK-25-010 | NIDDK | This Notice of Funding Opportunity (NOFO) invites applications for Cystic Fibrosis (CF) Research and Translation Core Centers. CF Research and Translation Core Centers are designed to support both… More | ||
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) | PA-24-191 | NIH | The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has… More | ||
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) | RFA-CA-24-022 | NCI | Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek… More | ||
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) | PA-24-192 | NIH | The purpose of the Mentored Quantitative Research Career Development Award (K25) is to attract to NIH-relevant research those investigators whose quantitative science and engineering research has… More | ||
Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) | RFA-AI-24-017 | NIAID | The purpose of this notice of funding opportunity (NOFO) is to support research that 1) defines associations between variations in human leukocyte antigen (HLA) and killer cell immunoglobulin-like… More | ||
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | The purpose of the NIH Mentored Research Scientist Development Award (K01) is to provide support and protected time (three to five years) for an intensive, supervised career development experience in… More | ||
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) | PA-24-193 | NIH | The purpose of the NIH Pathway to Independence Award (K99/R00) program is to increase and maintain a strong cohort of new and talented, NIH-supported, independent investigators. This program is… More |